Australia markets closed

Jack Nathan Medical Corp. (JNH.V)

TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
0.0250-0.0050 (-16.67%)
At close: 02:27PM EDT
Currency in CAD

Valuation measures4

Market cap (intra-day) 2.18M
Enterprise value 8.50M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.12
Price/book (mrq)7.84
Enterprise value/revenue 0.49
Enterprise value/EBITDA -2.13

Trading information

Stock price history

Beta (5Y monthly) -1.69
52-week change 3-76.19%
S&P500 52-week change 324.96%
52-week high 30.1200
52-week low 30.0250
50-day moving average 30.0426
200-day moving average 30.0531

Share statistics

Avg vol (3-month) 351.27k
Avg vol (10-day) 395.22k
Shares outstanding 587.1M
Implied shares outstanding 687.1M
Float 855.48M
% held by insiders 136.27%
% held by institutions 10.00%
Shares short (14 June 2024) 413.86k
Short ratio (14 June 2024) 40.02
Short % of float (14 June 2024) 4N/A
Short % of shares outstanding (14 June 2024) 40.00%
Shares short (prior month 15 May 2024) 4700

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 306 Oct 2020
Ex-dividend date 4N/A
Last split factor 21:3
Last split date 306 Oct 2020

Financial highlights

Fiscal year

Fiscal year ends 31 Jan 2024
Most-recent quarter (mrq)30 Apr 2024

Profitability

Profit margin -38.46%
Operating margin (ttm)-30.09%

Management effectiveness

Return on assets (ttm)-51.47%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)20.2M
Revenue per share (ttm)0.23
Quarterly revenue growth (yoy)24.90%
Gross profit (ttm)N/A
EBITDA -5.14M
Net income avi to common (ttm)-7.77M
Diluted EPS (ttm)-0.0800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.77M
Total cash per share (mrq)0.02
Total debt (mrq)12.78M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.81
Book value per share (mrq)-0.09

Cash flow statement

Operating cash flow (ttm)-7.83M
Levered free cash flow (ttm)-8.52M